Loading...
Keywords
Last Name
Institution

Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.

Hall EM, Yin DE, Goyal RK, Ahmed AA, Mitchell GS, St Peter SD, Flatt TG, Ahmed IA, Li W, Hendrickson RJ, August KJ, Myers GD. Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. J Immunother Cancer. 2021 Jan; 9(1).

View in: PubMed